Global Carbapenem Drugs Supply, Demand and Key Producers, 2026-2032
The global Carbapenem Drugs market size is expected to reach $ 6652 million by 2032, rising at a market growth of 4.5% CAGR during the forecast period (2026-2032).
Carbapenem drugs (finished dosage forms, primarily hospital-use sterile powder for injection and injectables, covering major molecules such as meropenem, imipenem/cilastatin, ertapenem, and doripenem) are a critical class of broad-spectrum beta-lactam antibacterials used for severe and complicated infections, including severe pneumonia, sepsis, complicated intra-abdominal and urinary tract infections, and hospital-acquired infections associated with multidrug-resistant Gram-negative pathogens, and are typically subject to strict antimicrobial stewardship policies. The upstream supply chain mainly consists of pharmaceutical-grade beta-lactam cores and key side-chain intermediates, excipients for sterile injectables such as buffers and stabilizers, water for injection, sterile packaging components, and GMP-compliant aseptic compounding, filling, lyophilization, and quality-control equipment, all requiring robust sterility assurance and batch consistency. Downstream customers are primarily general hospitals, tertiary hospitals, regional medical centers, and key specialty departments, with demand driven by centralized hospital procurement and public reimbursement systems. On an ex-factory basis, consolidated estimates for 2025 indicate global nominal capacity of approximately 7.42 hundred million vials, actual sales volume of around 5.96 hundred million vials, and an average global ex-factory selling price of about USD 7.9 per vial. Supported by aseptic manufacturing barriers but constrained by tender-driven pricing and intensified generic competition, manufacturers typically achieve gross margins in the range of 40%?55%, reflecting a market where compliance strength, supply reliability, and scale efficiency largely determine profitability.
From a market perspective, the hospital anti-infective segment for carbapenem drugs has reached a highly mature and tightly regulated stage. These agents are firmly positioned as key therapies for severe and complicated infections and are commonly included in restricted-use or stewardship-controlled drug lists across many healthcare systems. As original patents have expired, the market structure has shifted toward a multi-generic landscape, with competition increasingly centered on quality consistency, supply reliability, and regulatory compliance rather than brand differentiation or innovation. In terms of demand drivers, the rising proportion of critically ill patients, broader use of invasive medical procedures, and the growing complexity of infections caused by resistant Gram-negative pathogens continue to underpin demand for carbapenem drugs. Although antimicrobial stewardship policies emphasize rational and targeted use, hospitals still rely on this class of antibiotics for high-risk patients and severe infections where therapeutic certainty is essential, supporting a relatively stable role within inpatient treatment protocols. Looking ahead, market development is expected to focus on structural optimization and operational efficiency rather than rapid volume growth. Hospitals are placing greater emphasis on batch consistency, traceability, and uninterrupted supply, which may accelerate consolidation toward manufacturers with robust aseptic production capabilities and comprehensive quality systems. At the same time, the introduction of newer antimicrobial agents, combination regimens, and resistance-management strategies is likely to narrow the use of carbapenems in some indications, further concentrating their application in clearly defined clinical settings. Against this backdrop, both growth drivers and constraints will shape the long-term outlook. Cost-containment measures such as centralized procurement and reimbursement controls continue to exert pressure on pricing, while the high technical and regulatory thresholds of sterile manufacturing increase operational complexity and exposure to upstream supply risks. For manufacturers, long-term competitiveness in the carbapenem drug market will depend on maintaining compliance, cost discipline, and dependable supply within an increasingly controlled healthcare environment.
This report studies the global Carbapenem Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Carbapenem Drugs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Carbapenem Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Carbapenem Drugs total production and demand, 2021-2032, (K Units)
Global Carbapenem Drugs total production value, 2021-2032, (USD Million)
Global Carbapenem Drugs production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Carbapenem Drugs consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Carbapenem Drugs domestic production, consumption, key domestic manufacturers and share
Global Carbapenem Drugs production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Carbapenem Drugs production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Carbapenem Drugs production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Carbapenem Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gland Pharma, Merck, Savior Lifetec, Sumitomo Pharma, Pfizer, Aurobindo Pharma, Daewoong Pharmaceutical, ACS Dobfar, Fresenius, Sun Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Carbapenem Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Carbapenem Drugs Market, By Region:
1. How big is the global Carbapenem Drugs market?
2. What is the demand of the global Carbapenem Drugs market?
3. What is the year over year growth of the global Carbapenem Drugs market?
4. What is the production and production value of the global Carbapenem Drugs market?
5. Who are the key producers in the global Carbapenem Drugs market?
6. What are the growth factors driving the market demand?
Carbapenem drugs (finished dosage forms, primarily hospital-use sterile powder for injection and injectables, covering major molecules such as meropenem, imipenem/cilastatin, ertapenem, and doripenem) are a critical class of broad-spectrum beta-lactam antibacterials used for severe and complicated infections, including severe pneumonia, sepsis, complicated intra-abdominal and urinary tract infections, and hospital-acquired infections associated with multidrug-resistant Gram-negative pathogens, and are typically subject to strict antimicrobial stewardship policies. The upstream supply chain mainly consists of pharmaceutical-grade beta-lactam cores and key side-chain intermediates, excipients for sterile injectables such as buffers and stabilizers, water for injection, sterile packaging components, and GMP-compliant aseptic compounding, filling, lyophilization, and quality-control equipment, all requiring robust sterility assurance and batch consistency. Downstream customers are primarily general hospitals, tertiary hospitals, regional medical centers, and key specialty departments, with demand driven by centralized hospital procurement and public reimbursement systems. On an ex-factory basis, consolidated estimates for 2025 indicate global nominal capacity of approximately 7.42 hundred million vials, actual sales volume of around 5.96 hundred million vials, and an average global ex-factory selling price of about USD 7.9 per vial. Supported by aseptic manufacturing barriers but constrained by tender-driven pricing and intensified generic competition, manufacturers typically achieve gross margins in the range of 40%?55%, reflecting a market where compliance strength, supply reliability, and scale efficiency largely determine profitability.
From a market perspective, the hospital anti-infective segment for carbapenem drugs has reached a highly mature and tightly regulated stage. These agents are firmly positioned as key therapies for severe and complicated infections and are commonly included in restricted-use or stewardship-controlled drug lists across many healthcare systems. As original patents have expired, the market structure has shifted toward a multi-generic landscape, with competition increasingly centered on quality consistency, supply reliability, and regulatory compliance rather than brand differentiation or innovation. In terms of demand drivers, the rising proportion of critically ill patients, broader use of invasive medical procedures, and the growing complexity of infections caused by resistant Gram-negative pathogens continue to underpin demand for carbapenem drugs. Although antimicrobial stewardship policies emphasize rational and targeted use, hospitals still rely on this class of antibiotics for high-risk patients and severe infections where therapeutic certainty is essential, supporting a relatively stable role within inpatient treatment protocols. Looking ahead, market development is expected to focus on structural optimization and operational efficiency rather than rapid volume growth. Hospitals are placing greater emphasis on batch consistency, traceability, and uninterrupted supply, which may accelerate consolidation toward manufacturers with robust aseptic production capabilities and comprehensive quality systems. At the same time, the introduction of newer antimicrobial agents, combination regimens, and resistance-management strategies is likely to narrow the use of carbapenems in some indications, further concentrating their application in clearly defined clinical settings. Against this backdrop, both growth drivers and constraints will shape the long-term outlook. Cost-containment measures such as centralized procurement and reimbursement controls continue to exert pressure on pricing, while the high technical and regulatory thresholds of sterile manufacturing increase operational complexity and exposure to upstream supply risks. For manufacturers, long-term competitiveness in the carbapenem drug market will depend on maintaining compliance, cost discipline, and dependable supply within an increasingly controlled healthcare environment.
This report studies the global Carbapenem Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Carbapenem Drugs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Carbapenem Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Carbapenem Drugs total production and demand, 2021-2032, (K Units)
Global Carbapenem Drugs total production value, 2021-2032, (USD Million)
Global Carbapenem Drugs production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Carbapenem Drugs consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Carbapenem Drugs domestic production, consumption, key domestic manufacturers and share
Global Carbapenem Drugs production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Carbapenem Drugs production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Carbapenem Drugs production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Carbapenem Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gland Pharma, Merck, Savior Lifetec, Sumitomo Pharma, Pfizer, Aurobindo Pharma, Daewoong Pharmaceutical, ACS Dobfar, Fresenius, Sun Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Carbapenem Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Carbapenem Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Meropenem
- Imipenem
- Ertapenem
- Doripenem
- Others
- Sterile Powder for Injection
- Ready-to-use or Premixed Injection
- Others
- Severe Hospital-acquired Infections
- Drug-resistant Bacterial Infections
- Others
- Hospital
- Clinic
- Others
- Gland Pharma
- Merck
- Savior Lifetec
- Sumitomo Pharma
- Pfizer
- Aurobindo Pharma
- Daewoong Pharmaceutical
- ACS Dobfar
- Fresenius
- Sun Pharmaceutical
- Hikma Pharmaceuticals
- CSPC Pharmaceutical Group
- Shenzhen Haibin Pharmaceutical
- JW Pharmaceutical
- Taiwan Biotech
- Zhuhai United Laboratories
- Endo International
- Apotex
- Dr Reddy's Laboratories
- Chongqing Shenghuaxi Pharm
1. How big is the global Carbapenem Drugs market?
2. What is the demand of the global Carbapenem Drugs market?
3. What is the year over year growth of the global Carbapenem Drugs market?
4. What is the production and production value of the global Carbapenem Drugs market?
5. Who are the key producers in the global Carbapenem Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Carbapenem Drugs Introduction
1.2 World Carbapenem Drugs Supply & Forecast
1.2.1 World Carbapenem Drugs Production Value (2021 & 2025 & 2032)
1.2.2 World Carbapenem Drugs Production (2021-2032)
1.2.3 World Carbapenem Drugs Pricing Trends (2021-2032)
1.3 World Carbapenem Drugs Production by Region (Based on Production Site)
1.3.1 World Carbapenem Drugs Production Value by Region (2021-2032)
1.3.2 World Carbapenem Drugs Production by Region (2021-2032)
1.3.3 World Carbapenem Drugs Average Price by Region (2021-2032)
1.3.4 North America Carbapenem Drugs Production (2021-2032)
1.3.5 Europe Carbapenem Drugs Production (2021-2032)
1.3.6 China Carbapenem Drugs Production (2021-2032)
1.3.7 Japan Carbapenem Drugs Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Carbapenem Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Carbapenem Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Carbapenem Drugs Demand (2021-2032)
2.2 World Carbapenem Drugs Consumption by Region
2.2.1 World Carbapenem Drugs Consumption by Region (2021-2026)
2.2.2 World Carbapenem Drugs Consumption Forecast by Region (2027-2032)
2.3 United States Carbapenem Drugs Consumption (2021-2032)
2.4 China Carbapenem Drugs Consumption (2021-2032)
2.5 Europe Carbapenem Drugs Consumption (2021-2032)
2.6 Japan Carbapenem Drugs Consumption (2021-2032)
2.7 South Korea Carbapenem Drugs Consumption (2021-2032)
2.8 ASEAN Carbapenem Drugs Consumption (2021-2032)
2.9 India Carbapenem Drugs Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Carbapenem Drugs Production Value by Manufacturer (2021-2026)
3.2 World Carbapenem Drugs Production by Manufacturer (2021-2026)
3.3 World Carbapenem Drugs Average Price by Manufacturer (2021-2026)
3.4 Carbapenem Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Carbapenem Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Carbapenem Drugs in 2025
3.5.3 Global Concentration Ratios (CR8) for Carbapenem Drugs in 2025
3.6 Carbapenem Drugs Market: Overall Company Footprint Analysis
3.6.1 Carbapenem Drugs Market: Region Footprint
3.6.2 Carbapenem Drugs Market: Company Product Type Footprint
3.6.3 Carbapenem Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Carbapenem Drugs Production Value Comparison
4.1.1 United States VS China: Carbapenem Drugs Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Carbapenem Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Carbapenem Drugs Production Comparison
4.2.1 United States VS China: Carbapenem Drugs Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Carbapenem Drugs Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Carbapenem Drugs Consumption Comparison
4.3.1 United States VS China: Carbapenem Drugs Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Carbapenem Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Carbapenem Drugs Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Carbapenem Drugs Production Value (2021-2026)
4.4.3 United States Based Manufacturers Carbapenem Drugs Production (2021-2026)
4.5 China Based Carbapenem Drugs Manufacturers and Market Share
4.5.1 China Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Carbapenem Drugs Production Value (2021-2026)
4.5.3 China Based Manufacturers Carbapenem Drugs Production (2021-2026)
4.6 Rest of World Based Carbapenem Drugs Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Carbapenem Drugs Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Carbapenem Drugs Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Carbapenem Drugs Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Meropenem
5.2.2 Imipenem
5.2.3 Ertapenem
5.2.4 Doripenem
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Carbapenem Drugs Production by Type (2021-2032)
5.3.2 World Carbapenem Drugs Production Value by Type (2021-2032)
5.3.3 World Carbapenem Drugs Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DOSAGE FORM
6.1 World Carbapenem Drugs Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage Form
6.2.1 Sterile Powder for Injection
6.2.2 Ready-to-use or Premixed Injection
6.2.3 Others
6.3 Market Segment by Dosage Form
6.3.1 World Carbapenem Drugs Production by Dosage Form (2021-2032)
6.3.2 World Carbapenem Drugs Production Value by Dosage Form (2021-2032)
6.3.3 World Carbapenem Drugs Average Price by Dosage Form (2021-2032)
7 MARKET ANALYSIS BY CLINICAL INDICATION
7.1 World Carbapenem Drugs Market Size Overview by Clinical Indication: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Clinical Indication
7.2.1 Severe Hospital-acquired Infections
7.2.2 Drug-resistant Bacterial Infections
7.2.3 Others
7.3 Market Segment by Clinical Indication
7.3.1 World Carbapenem Drugs Production by Clinical Indication (2021-2032)
7.3.2 World Carbapenem Drugs Production Value by Clinical Indication (2021-2032)
7.3.3 World Carbapenem Drugs Average Price by Clinical Indication (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Carbapenem Drugs Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Carbapenem Drugs Production by Application (2021-2032)
8.3.2 World Carbapenem Drugs Production Value by Application (2021-2032)
8.3.3 World Carbapenem Drugs Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Gland Pharma
9.1.1 Gland Pharma Details
9.1.2 Gland Pharma Major Business
9.1.3 Gland Pharma Carbapenem Drugs Product and Services
9.1.4 Gland Pharma Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Gland Pharma Recent Developments/Updates
9.1.6 Gland Pharma Competitive Strengths & Weaknesses
9.2 Merck
9.2.1 Merck Details
9.2.2 Merck Major Business
9.2.3 Merck Carbapenem Drugs Product and Services
9.2.4 Merck Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Merck Recent Developments/Updates
9.2.6 Merck Competitive Strengths & Weaknesses
9.3 Savior Lifetec
9.3.1 Savior Lifetec Details
9.3.2 Savior Lifetec Major Business
9.3.3 Savior Lifetec Carbapenem Drugs Product and Services
9.3.4 Savior Lifetec Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Savior Lifetec Recent Developments/Updates
9.3.6 Savior Lifetec Competitive Strengths & Weaknesses
9.4 Sumitomo Pharma
9.4.1 Sumitomo Pharma Details
9.4.2 Sumitomo Pharma Major Business
9.4.3 Sumitomo Pharma Carbapenem Drugs Product and Services
9.4.4 Sumitomo Pharma Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Sumitomo Pharma Recent Developments/Updates
9.4.6 Sumitomo Pharma Competitive Strengths & Weaknesses
9.5 Pfizer
9.5.1 Pfizer Details
9.5.2 Pfizer Major Business
9.5.3 Pfizer Carbapenem Drugs Product and Services
9.5.4 Pfizer Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Pfizer Recent Developments/Updates
9.5.6 Pfizer Competitive Strengths & Weaknesses
9.6 Aurobindo Pharma
9.6.1 Aurobindo Pharma Details
9.6.2 Aurobindo Pharma Major Business
9.6.3 Aurobindo Pharma Carbapenem Drugs Product and Services
9.6.4 Aurobindo Pharma Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Aurobindo Pharma Recent Developments/Updates
9.6.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.7 Daewoong Pharmaceutical
9.7.1 Daewoong Pharmaceutical Details
9.7.2 Daewoong Pharmaceutical Major Business
9.7.3 Daewoong Pharmaceutical Carbapenem Drugs Product and Services
9.7.4 Daewoong Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Daewoong Pharmaceutical Recent Developments/Updates
9.7.6 Daewoong Pharmaceutical Competitive Strengths & Weaknesses
9.8 ACS Dobfar
9.8.1 ACS Dobfar Details
9.8.2 ACS Dobfar Major Business
9.8.3 ACS Dobfar Carbapenem Drugs Product and Services
9.8.4 ACS Dobfar Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 ACS Dobfar Recent Developments/Updates
9.8.6 ACS Dobfar Competitive Strengths & Weaknesses
9.9 Fresenius
9.9.1 Fresenius Details
9.9.2 Fresenius Major Business
9.9.3 Fresenius Carbapenem Drugs Product and Services
9.9.4 Fresenius Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Fresenius Recent Developments/Updates
9.9.6 Fresenius Competitive Strengths & Weaknesses
9.10 Sun Pharmaceutical
9.10.1 Sun Pharmaceutical Details
9.10.2 Sun Pharmaceutical Major Business
9.10.3 Sun Pharmaceutical Carbapenem Drugs Product and Services
9.10.4 Sun Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Sun Pharmaceutical Recent Developments/Updates
9.10.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
9.11 Hikma Pharmaceuticals
9.11.1 Hikma Pharmaceuticals Details
9.11.2 Hikma Pharmaceuticals Major Business
9.11.3 Hikma Pharmaceuticals Carbapenem Drugs Product and Services
9.11.4 Hikma Pharmaceuticals Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Hikma Pharmaceuticals Recent Developments/Updates
9.11.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
9.12 CSPC Pharmaceutical Group
9.12.1 CSPC Pharmaceutical Group Details
9.12.2 CSPC Pharmaceutical Group Major Business
9.12.3 CSPC Pharmaceutical Group Carbapenem Drugs Product and Services
9.12.4 CSPC Pharmaceutical Group Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 CSPC Pharmaceutical Group Recent Developments/Updates
9.12.6 CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
9.13 Shenzhen Haibin Pharmaceutical
9.13.1 Shenzhen Haibin Pharmaceutical Details
9.13.2 Shenzhen Haibin Pharmaceutical Major Business
9.13.3 Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product and Services
9.13.4 Shenzhen Haibin Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
9.13.6 Shenzhen Haibin Pharmaceutical Competitive Strengths & Weaknesses
9.14 JW Pharmaceutical
9.14.1 JW Pharmaceutical Details
9.14.2 JW Pharmaceutical Major Business
9.14.3 JW Pharmaceutical Carbapenem Drugs Product and Services
9.14.4 JW Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 JW Pharmaceutical Recent Developments/Updates
9.14.6 JW Pharmaceutical Competitive Strengths & Weaknesses
9.15 Taiwan Biotech
9.15.1 Taiwan Biotech Details
9.15.2 Taiwan Biotech Major Business
9.15.3 Taiwan Biotech Carbapenem Drugs Product and Services
9.15.4 Taiwan Biotech Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Taiwan Biotech Recent Developments/Updates
9.15.6 Taiwan Biotech Competitive Strengths & Weaknesses
9.16 Zhuhai United Laboratories
9.16.1 Zhuhai United Laboratories Details
9.16.2 Zhuhai United Laboratories Major Business
9.16.3 Zhuhai United Laboratories Carbapenem Drugs Product and Services
9.16.4 Zhuhai United Laboratories Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Zhuhai United Laboratories Recent Developments/Updates
9.16.6 Zhuhai United Laboratories Competitive Strengths & Weaknesses
9.17 Endo International
9.17.1 Endo International Details
9.17.2 Endo International Major Business
9.17.3 Endo International Carbapenem Drugs Product and Services
9.17.4 Endo International Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Endo International Recent Developments/Updates
9.17.6 Endo International Competitive Strengths & Weaknesses
9.18 Apotex
9.18.1 Apotex Details
9.18.2 Apotex Major Business
9.18.3 Apotex Carbapenem Drugs Product and Services
9.18.4 Apotex Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Apotex Recent Developments/Updates
9.18.6 Apotex Competitive Strengths & Weaknesses
9.19 Dr Reddy's Laboratories
9.19.1 Dr Reddy's Laboratories Details
9.19.2 Dr Reddy's Laboratories Major Business
9.19.3 Dr Reddy's Laboratories Carbapenem Drugs Product and Services
9.19.4 Dr Reddy's Laboratories Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Dr Reddy's Laboratories Recent Developments/Updates
9.19.6 Dr Reddy's Laboratories Competitive Strengths & Weaknesses
9.20 Chongqing Shenghuaxi Pharm
9.20.1 Chongqing Shenghuaxi Pharm Details
9.20.2 Chongqing Shenghuaxi Pharm Major Business
9.20.3 Chongqing Shenghuaxi Pharm Carbapenem Drugs Product and Services
9.20.4 Chongqing Shenghuaxi Pharm Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Chongqing Shenghuaxi Pharm Recent Developments/Updates
9.20.6 Chongqing Shenghuaxi Pharm Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Carbapenem Drugs Industry Chain
10.2 Carbapenem Drugs Upstream Analysis
10.2.1 Carbapenem Drugs Core Raw Materials
10.2.2 Main Manufacturers of Carbapenem Drugs Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Carbapenem Drugs Production Mode
10.6 Carbapenem Drugs Procurement Model
10.7 Carbapenem Drugs Industry Sales Model and Sales Channels
10.7.1 Carbapenem Drugs Sales Model
10.7.2 Carbapenem Drugs Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Carbapenem Drugs Introduction
1.2 World Carbapenem Drugs Supply & Forecast
1.2.1 World Carbapenem Drugs Production Value (2021 & 2025 & 2032)
1.2.2 World Carbapenem Drugs Production (2021-2032)
1.2.3 World Carbapenem Drugs Pricing Trends (2021-2032)
1.3 World Carbapenem Drugs Production by Region (Based on Production Site)
1.3.1 World Carbapenem Drugs Production Value by Region (2021-2032)
1.3.2 World Carbapenem Drugs Production by Region (2021-2032)
1.3.3 World Carbapenem Drugs Average Price by Region (2021-2032)
1.3.4 North America Carbapenem Drugs Production (2021-2032)
1.3.5 Europe Carbapenem Drugs Production (2021-2032)
1.3.6 China Carbapenem Drugs Production (2021-2032)
1.3.7 Japan Carbapenem Drugs Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Carbapenem Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Carbapenem Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Carbapenem Drugs Demand (2021-2032)
2.2 World Carbapenem Drugs Consumption by Region
2.2.1 World Carbapenem Drugs Consumption by Region (2021-2026)
2.2.2 World Carbapenem Drugs Consumption Forecast by Region (2027-2032)
2.3 United States Carbapenem Drugs Consumption (2021-2032)
2.4 China Carbapenem Drugs Consumption (2021-2032)
2.5 Europe Carbapenem Drugs Consumption (2021-2032)
2.6 Japan Carbapenem Drugs Consumption (2021-2032)
2.7 South Korea Carbapenem Drugs Consumption (2021-2032)
2.8 ASEAN Carbapenem Drugs Consumption (2021-2032)
2.9 India Carbapenem Drugs Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Carbapenem Drugs Production Value by Manufacturer (2021-2026)
3.2 World Carbapenem Drugs Production by Manufacturer (2021-2026)
3.3 World Carbapenem Drugs Average Price by Manufacturer (2021-2026)
3.4 Carbapenem Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Carbapenem Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Carbapenem Drugs in 2025
3.5.3 Global Concentration Ratios (CR8) for Carbapenem Drugs in 2025
3.6 Carbapenem Drugs Market: Overall Company Footprint Analysis
3.6.1 Carbapenem Drugs Market: Region Footprint
3.6.2 Carbapenem Drugs Market: Company Product Type Footprint
3.6.3 Carbapenem Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Carbapenem Drugs Production Value Comparison
4.1.1 United States VS China: Carbapenem Drugs Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Carbapenem Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Carbapenem Drugs Production Comparison
4.2.1 United States VS China: Carbapenem Drugs Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Carbapenem Drugs Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Carbapenem Drugs Consumption Comparison
4.3.1 United States VS China: Carbapenem Drugs Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Carbapenem Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Carbapenem Drugs Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Carbapenem Drugs Production Value (2021-2026)
4.4.3 United States Based Manufacturers Carbapenem Drugs Production (2021-2026)
4.5 China Based Carbapenem Drugs Manufacturers and Market Share
4.5.1 China Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Carbapenem Drugs Production Value (2021-2026)
4.5.3 China Based Manufacturers Carbapenem Drugs Production (2021-2026)
4.6 Rest of World Based Carbapenem Drugs Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Carbapenem Drugs Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Carbapenem Drugs Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Carbapenem Drugs Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Meropenem
5.2.2 Imipenem
5.2.3 Ertapenem
5.2.4 Doripenem
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Carbapenem Drugs Production by Type (2021-2032)
5.3.2 World Carbapenem Drugs Production Value by Type (2021-2032)
5.3.3 World Carbapenem Drugs Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DOSAGE FORM
6.1 World Carbapenem Drugs Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage Form
6.2.1 Sterile Powder for Injection
6.2.2 Ready-to-use or Premixed Injection
6.2.3 Others
6.3 Market Segment by Dosage Form
6.3.1 World Carbapenem Drugs Production by Dosage Form (2021-2032)
6.3.2 World Carbapenem Drugs Production Value by Dosage Form (2021-2032)
6.3.3 World Carbapenem Drugs Average Price by Dosage Form (2021-2032)
7 MARKET ANALYSIS BY CLINICAL INDICATION
7.1 World Carbapenem Drugs Market Size Overview by Clinical Indication: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Clinical Indication
7.2.1 Severe Hospital-acquired Infections
7.2.2 Drug-resistant Bacterial Infections
7.2.3 Others
7.3 Market Segment by Clinical Indication
7.3.1 World Carbapenem Drugs Production by Clinical Indication (2021-2032)
7.3.2 World Carbapenem Drugs Production Value by Clinical Indication (2021-2032)
7.3.3 World Carbapenem Drugs Average Price by Clinical Indication (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Carbapenem Drugs Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Carbapenem Drugs Production by Application (2021-2032)
8.3.2 World Carbapenem Drugs Production Value by Application (2021-2032)
8.3.3 World Carbapenem Drugs Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Gland Pharma
9.1.1 Gland Pharma Details
9.1.2 Gland Pharma Major Business
9.1.3 Gland Pharma Carbapenem Drugs Product and Services
9.1.4 Gland Pharma Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Gland Pharma Recent Developments/Updates
9.1.6 Gland Pharma Competitive Strengths & Weaknesses
9.2 Merck
9.2.1 Merck Details
9.2.2 Merck Major Business
9.2.3 Merck Carbapenem Drugs Product and Services
9.2.4 Merck Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Merck Recent Developments/Updates
9.2.6 Merck Competitive Strengths & Weaknesses
9.3 Savior Lifetec
9.3.1 Savior Lifetec Details
9.3.2 Savior Lifetec Major Business
9.3.3 Savior Lifetec Carbapenem Drugs Product and Services
9.3.4 Savior Lifetec Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Savior Lifetec Recent Developments/Updates
9.3.6 Savior Lifetec Competitive Strengths & Weaknesses
9.4 Sumitomo Pharma
9.4.1 Sumitomo Pharma Details
9.4.2 Sumitomo Pharma Major Business
9.4.3 Sumitomo Pharma Carbapenem Drugs Product and Services
9.4.4 Sumitomo Pharma Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Sumitomo Pharma Recent Developments/Updates
9.4.6 Sumitomo Pharma Competitive Strengths & Weaknesses
9.5 Pfizer
9.5.1 Pfizer Details
9.5.2 Pfizer Major Business
9.5.3 Pfizer Carbapenem Drugs Product and Services
9.5.4 Pfizer Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Pfizer Recent Developments/Updates
9.5.6 Pfizer Competitive Strengths & Weaknesses
9.6 Aurobindo Pharma
9.6.1 Aurobindo Pharma Details
9.6.2 Aurobindo Pharma Major Business
9.6.3 Aurobindo Pharma Carbapenem Drugs Product and Services
9.6.4 Aurobindo Pharma Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Aurobindo Pharma Recent Developments/Updates
9.6.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.7 Daewoong Pharmaceutical
9.7.1 Daewoong Pharmaceutical Details
9.7.2 Daewoong Pharmaceutical Major Business
9.7.3 Daewoong Pharmaceutical Carbapenem Drugs Product and Services
9.7.4 Daewoong Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Daewoong Pharmaceutical Recent Developments/Updates
9.7.6 Daewoong Pharmaceutical Competitive Strengths & Weaknesses
9.8 ACS Dobfar
9.8.1 ACS Dobfar Details
9.8.2 ACS Dobfar Major Business
9.8.3 ACS Dobfar Carbapenem Drugs Product and Services
9.8.4 ACS Dobfar Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 ACS Dobfar Recent Developments/Updates
9.8.6 ACS Dobfar Competitive Strengths & Weaknesses
9.9 Fresenius
9.9.1 Fresenius Details
9.9.2 Fresenius Major Business
9.9.3 Fresenius Carbapenem Drugs Product and Services
9.9.4 Fresenius Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Fresenius Recent Developments/Updates
9.9.6 Fresenius Competitive Strengths & Weaknesses
9.10 Sun Pharmaceutical
9.10.1 Sun Pharmaceutical Details
9.10.2 Sun Pharmaceutical Major Business
9.10.3 Sun Pharmaceutical Carbapenem Drugs Product and Services
9.10.4 Sun Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Sun Pharmaceutical Recent Developments/Updates
9.10.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
9.11 Hikma Pharmaceuticals
9.11.1 Hikma Pharmaceuticals Details
9.11.2 Hikma Pharmaceuticals Major Business
9.11.3 Hikma Pharmaceuticals Carbapenem Drugs Product and Services
9.11.4 Hikma Pharmaceuticals Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Hikma Pharmaceuticals Recent Developments/Updates
9.11.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
9.12 CSPC Pharmaceutical Group
9.12.1 CSPC Pharmaceutical Group Details
9.12.2 CSPC Pharmaceutical Group Major Business
9.12.3 CSPC Pharmaceutical Group Carbapenem Drugs Product and Services
9.12.4 CSPC Pharmaceutical Group Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 CSPC Pharmaceutical Group Recent Developments/Updates
9.12.6 CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
9.13 Shenzhen Haibin Pharmaceutical
9.13.1 Shenzhen Haibin Pharmaceutical Details
9.13.2 Shenzhen Haibin Pharmaceutical Major Business
9.13.3 Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product and Services
9.13.4 Shenzhen Haibin Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
9.13.6 Shenzhen Haibin Pharmaceutical Competitive Strengths & Weaknesses
9.14 JW Pharmaceutical
9.14.1 JW Pharmaceutical Details
9.14.2 JW Pharmaceutical Major Business
9.14.3 JW Pharmaceutical Carbapenem Drugs Product and Services
9.14.4 JW Pharmaceutical Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 JW Pharmaceutical Recent Developments/Updates
9.14.6 JW Pharmaceutical Competitive Strengths & Weaknesses
9.15 Taiwan Biotech
9.15.1 Taiwan Biotech Details
9.15.2 Taiwan Biotech Major Business
9.15.3 Taiwan Biotech Carbapenem Drugs Product and Services
9.15.4 Taiwan Biotech Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Taiwan Biotech Recent Developments/Updates
9.15.6 Taiwan Biotech Competitive Strengths & Weaknesses
9.16 Zhuhai United Laboratories
9.16.1 Zhuhai United Laboratories Details
9.16.2 Zhuhai United Laboratories Major Business
9.16.3 Zhuhai United Laboratories Carbapenem Drugs Product and Services
9.16.4 Zhuhai United Laboratories Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Zhuhai United Laboratories Recent Developments/Updates
9.16.6 Zhuhai United Laboratories Competitive Strengths & Weaknesses
9.17 Endo International
9.17.1 Endo International Details
9.17.2 Endo International Major Business
9.17.3 Endo International Carbapenem Drugs Product and Services
9.17.4 Endo International Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Endo International Recent Developments/Updates
9.17.6 Endo International Competitive Strengths & Weaknesses
9.18 Apotex
9.18.1 Apotex Details
9.18.2 Apotex Major Business
9.18.3 Apotex Carbapenem Drugs Product and Services
9.18.4 Apotex Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Apotex Recent Developments/Updates
9.18.6 Apotex Competitive Strengths & Weaknesses
9.19 Dr Reddy's Laboratories
9.19.1 Dr Reddy's Laboratories Details
9.19.2 Dr Reddy's Laboratories Major Business
9.19.3 Dr Reddy's Laboratories Carbapenem Drugs Product and Services
9.19.4 Dr Reddy's Laboratories Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Dr Reddy's Laboratories Recent Developments/Updates
9.19.6 Dr Reddy's Laboratories Competitive Strengths & Weaknesses
9.20 Chongqing Shenghuaxi Pharm
9.20.1 Chongqing Shenghuaxi Pharm Details
9.20.2 Chongqing Shenghuaxi Pharm Major Business
9.20.3 Chongqing Shenghuaxi Pharm Carbapenem Drugs Product and Services
9.20.4 Chongqing Shenghuaxi Pharm Carbapenem Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Chongqing Shenghuaxi Pharm Recent Developments/Updates
9.20.6 Chongqing Shenghuaxi Pharm Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Carbapenem Drugs Industry Chain
10.2 Carbapenem Drugs Upstream Analysis
10.2.1 Carbapenem Drugs Core Raw Materials
10.2.2 Main Manufacturers of Carbapenem Drugs Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Carbapenem Drugs Production Mode
10.6 Carbapenem Drugs Procurement Model
10.7 Carbapenem Drugs Industry Sales Model and Sales Channels
10.7.1 Carbapenem Drugs Sales Model
10.7.2 Carbapenem Drugs Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Carbapenem Drugs Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Carbapenem Drugs Production Value by Region (2021-2026) & (USD Million)
Table 3. World Carbapenem Drugs Production Value by Region (2027-2032) & (USD Million)
Table 4. World Carbapenem Drugs Production Value Market Share by Region (2021-2026)
Table 5. World Carbapenem Drugs Production Value Market Share by Region (2027-2032)
Table 6. World Carbapenem Drugs Production by Region (2021-2026) & (K Units)
Table 7. World Carbapenem Drugs Production by Region (2027-2032) & (K Units)
Table 8. World Carbapenem Drugs Production Market Share by Region (2021-2026)
Table 9. World Carbapenem Drugs Production Market Share by Region (2027-2032)
Table 10. World Carbapenem Drugs Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Carbapenem Drugs Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Carbapenem Drugs Major Market Trends
Table 13. World Carbapenem Drugs Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Carbapenem Drugs Consumption by Region (2021-2026) & (K Units)
Table 15. World Carbapenem Drugs Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Carbapenem Drugs Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Carbapenem Drugs Producers in 2025
Table 18. World Carbapenem Drugs Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Carbapenem Drugs Producers in 2025
Table 20. World Carbapenem Drugs Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Carbapenem Drugs Company Evaluation Quadrant
Table 22. World Carbapenem Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Carbapenem Drugs Production Site of Key Manufacturer
Table 24. Carbapenem Drugs Market: Company Product Type Footprint
Table 25. Carbapenem Drugs Market: Company Product Application Footprint
Table 26. Carbapenem Drugs Competitive Factors
Table 27. Carbapenem Drugs New Entrant and Capacity Expansion Plans
Table 28. Carbapenem Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Carbapenem Drugs Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Carbapenem Drugs Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Carbapenem Drugs Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Carbapenem Drugs Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Carbapenem Drugs Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Carbapenem Drugs Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Carbapenem Drugs Production Market Share (2021-2026)
Table 37. China Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Carbapenem Drugs Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Carbapenem Drugs Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Carbapenem Drugs Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Carbapenem Drugs Production Market Share (2021-2026)
Table 42. Rest of World Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Carbapenem Drugs Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Carbapenem Drugs Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Carbapenem Drugs Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Carbapenem Drugs Production Market Share (2021-2026)
Table 47. World Carbapenem Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Carbapenem Drugs Production by Type (2021-2026) & (K Units)
Table 49. World Carbapenem Drugs Production by Type (2027-2032) & (K Units)
Table 50. World Carbapenem Drugs Production Value by Type (2021-2026) & (USD Million)
Table 51. World Carbapenem Drugs Production Value by Type (2027-2032) & (USD Million)
Table 52. World Carbapenem Drugs Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Carbapenem Drugs Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Carbapenem Drugs Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 55. World Carbapenem Drugs Production by Dosage Form (2021-2026) & (K Units)
Table 56. World Carbapenem Drugs Production by Dosage Form (2027-2032) & (K Units)
Table 57. World Carbapenem Drugs Production Value by Dosage Form (2021-2026) & (USD Million)
Table 58. World Carbapenem Drugs Production Value by Dosage Form (2027-2032) & (USD Million)
Table 59. World Carbapenem Drugs Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 60. World Carbapenem Drugs Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 61. World Carbapenem Drugs Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Table 62. World Carbapenem Drugs Production by Clinical Indication (2021-2026) & (K Units)
Table 63. World Carbapenem Drugs Production by Clinical Indication (2027-2032) & (K Units)
Table 64. World Carbapenem Drugs Production Value by Clinical Indication (2021-2026) & (USD Million)
Table 65. World Carbapenem Drugs Production Value by Clinical Indication (2027-2032) & (USD Million)
Table 66. World Carbapenem Drugs Average Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 67. World Carbapenem Drugs Average Price by Clinical Indication (2027-2032) & (US$/Unit)
Table 68. World Carbapenem Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Carbapenem Drugs Production by Application (2021-2026) & (K Units)
Table 70. World Carbapenem Drugs Production by Application (2027-2032) & (K Units)
Table 71. World Carbapenem Drugs Production Value by Application (2021-2026) & (USD Million)
Table 72. World Carbapenem Drugs Production Value by Application (2027-2032) & (USD Million)
Table 73. World Carbapenem Drugs Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Carbapenem Drugs Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Gland Pharma Basic Information, Manufacturing Base and Competitors
Table 76. Gland Pharma Major Business
Table 77. Gland Pharma Carbapenem Drugs Product and Services
Table 78. Gland Pharma Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Gland Pharma Recent Developments/Updates
Table 80. Gland Pharma Competitive Strengths & Weaknesses
Table 81. Merck Basic Information, Manufacturing Base and Competitors
Table 82. Merck Major Business
Table 83. Merck Carbapenem Drugs Product and Services
Table 84. Merck Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Merck Recent Developments/Updates
Table 86. Merck Competitive Strengths & Weaknesses
Table 87. Savior Lifetec Basic Information, Manufacturing Base and Competitors
Table 88. Savior Lifetec Major Business
Table 89. Savior Lifetec Carbapenem Drugs Product and Services
Table 90. Savior Lifetec Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Savior Lifetec Recent Developments/Updates
Table 92. Savior Lifetec Competitive Strengths & Weaknesses
Table 93. Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 94. Sumitomo Pharma Major Business
Table 95. Sumitomo Pharma Carbapenem Drugs Product and Services
Table 96. Sumitomo Pharma Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Sumitomo Pharma Recent Developments/Updates
Table 98. Sumitomo Pharma Competitive Strengths & Weaknesses
Table 99. Pfizer Basic Information, Manufacturing Base and Competitors
Table 100. Pfizer Major Business
Table 101. Pfizer Carbapenem Drugs Product and Services
Table 102. Pfizer Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Pfizer Recent Developments/Updates
Table 104. Pfizer Competitive Strengths & Weaknesses
Table 105. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 106. Aurobindo Pharma Major Business
Table 107. Aurobindo Pharma Carbapenem Drugs Product and Services
Table 108. Aurobindo Pharma Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Aurobindo Pharma Recent Developments/Updates
Table 110. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 111. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 112. Daewoong Pharmaceutical Major Business
Table 113. Daewoong Pharmaceutical Carbapenem Drugs Product and Services
Table 114. Daewoong Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Daewoong Pharmaceutical Recent Developments/Updates
Table 116. Daewoong Pharmaceutical Competitive Strengths & Weaknesses
Table 117. ACS Dobfar Basic Information, Manufacturing Base and Competitors
Table 118. ACS Dobfar Major Business
Table 119. ACS Dobfar Carbapenem Drugs Product and Services
Table 120. ACS Dobfar Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. ACS Dobfar Recent Developments/Updates
Table 122. ACS Dobfar Competitive Strengths & Weaknesses
Table 123. Fresenius Basic Information, Manufacturing Base and Competitors
Table 124. Fresenius Major Business
Table 125. Fresenius Carbapenem Drugs Product and Services
Table 126. Fresenius Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Fresenius Recent Developments/Updates
Table 128. Fresenius Competitive Strengths & Weaknesses
Table 129. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 130. Sun Pharmaceutical Major Business
Table 131. Sun Pharmaceutical Carbapenem Drugs Product and Services
Table 132. Sun Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Sun Pharmaceutical Recent Developments/Updates
Table 134. Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 135. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 136. Hikma Pharmaceuticals Major Business
Table 137. Hikma Pharmaceuticals Carbapenem Drugs Product and Services
Table 138. Hikma Pharmaceuticals Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Hikma Pharmaceuticals Recent Developments/Updates
Table 140. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 141. CSPC Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 142. CSPC Pharmaceutical Group Major Business
Table 143. CSPC Pharmaceutical Group Carbapenem Drugs Product and Services
Table 144. CSPC Pharmaceutical Group Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. CSPC Pharmaceutical Group Recent Developments/Updates
Table 146. CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
Table 147. Shenzhen Haibin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 148. Shenzhen Haibin Pharmaceutical Major Business
Table 149. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product and Services
Table 150. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 152. Shenzhen Haibin Pharmaceutical Competitive Strengths & Weaknesses
Table 153. JW Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 154. JW Pharmaceutical Major Business
Table 155. JW Pharmaceutical Carbapenem Drugs Product and Services
Table 156. JW Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. JW Pharmaceutical Recent Developments/Updates
Table 158. JW Pharmaceutical Competitive Strengths & Weaknesses
Table 159. Taiwan Biotech Basic Information, Manufacturing Base and Competitors
Table 160. Taiwan Biotech Major Business
Table 161. Taiwan Biotech Carbapenem Drugs Product and Services
Table 162. Taiwan Biotech Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Taiwan Biotech Recent Developments/Updates
Table 164. Taiwan Biotech Competitive Strengths & Weaknesses
Table 165. Zhuhai United Laboratories Basic Information, Manufacturing Base and Competitors
Table 166. Zhuhai United Laboratories Major Business
Table 167. Zhuhai United Laboratories Carbapenem Drugs Product and Services
Table 168. Zhuhai United Laboratories Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Zhuhai United Laboratories Recent Developments/Updates
Table 170. Zhuhai United Laboratories Competitive Strengths & Weaknesses
Table 171. Endo International Basic Information, Manufacturing Base and Competitors
Table 172. Endo International Major Business
Table 173. Endo International Carbapenem Drugs Product and Services
Table 174. Endo International Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Endo International Recent Developments/Updates
Table 176. Endo International Competitive Strengths & Weaknesses
Table 177. Apotex Basic Information, Manufacturing Base and Competitors
Table 178. Apotex Major Business
Table 179. Apotex Carbapenem Drugs Product and Services
Table 180. Apotex Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Apotex Recent Developments/Updates
Table 182. Apotex Competitive Strengths & Weaknesses
Table 183. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 184. Dr Reddy's Laboratories Major Business
Table 185. Dr Reddy's Laboratories Carbapenem Drugs Product and Services
Table 186. Dr Reddy's Laboratories Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Dr Reddy's Laboratories Recent Developments/Updates
Table 188. Dr Reddy's Laboratories Competitive Strengths & Weaknesses
Table 189. Chongqing Shenghuaxi Pharm Basic Information, Manufacturing Base and Competitors
Table 190. Chongqing Shenghuaxi Pharm Major Business
Table 191. Chongqing Shenghuaxi Pharm Carbapenem Drugs Product and Services
Table 192. Chongqing Shenghuaxi Pharm Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Chongqing Shenghuaxi Pharm Recent Developments/Updates
Table 194. Chongqing Shenghuaxi Pharm Competitive Strengths & Weaknesses
Table 195. Global Key Players of Carbapenem Drugs Upstream (Raw Materials)
Table 196. Global Carbapenem Drugs Typical Customers
Table 197. Carbapenem Drugs Typical Distributors
Table 1. World Carbapenem Drugs Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Carbapenem Drugs Production Value by Region (2021-2026) & (USD Million)
Table 3. World Carbapenem Drugs Production Value by Region (2027-2032) & (USD Million)
Table 4. World Carbapenem Drugs Production Value Market Share by Region (2021-2026)
Table 5. World Carbapenem Drugs Production Value Market Share by Region (2027-2032)
Table 6. World Carbapenem Drugs Production by Region (2021-2026) & (K Units)
Table 7. World Carbapenem Drugs Production by Region (2027-2032) & (K Units)
Table 8. World Carbapenem Drugs Production Market Share by Region (2021-2026)
Table 9. World Carbapenem Drugs Production Market Share by Region (2027-2032)
Table 10. World Carbapenem Drugs Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Carbapenem Drugs Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Carbapenem Drugs Major Market Trends
Table 13. World Carbapenem Drugs Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Carbapenem Drugs Consumption by Region (2021-2026) & (K Units)
Table 15. World Carbapenem Drugs Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Carbapenem Drugs Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Carbapenem Drugs Producers in 2025
Table 18. World Carbapenem Drugs Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Carbapenem Drugs Producers in 2025
Table 20. World Carbapenem Drugs Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Carbapenem Drugs Company Evaluation Quadrant
Table 22. World Carbapenem Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Carbapenem Drugs Production Site of Key Manufacturer
Table 24. Carbapenem Drugs Market: Company Product Type Footprint
Table 25. Carbapenem Drugs Market: Company Product Application Footprint
Table 26. Carbapenem Drugs Competitive Factors
Table 27. Carbapenem Drugs New Entrant and Capacity Expansion Plans
Table 28. Carbapenem Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Carbapenem Drugs Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Carbapenem Drugs Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Carbapenem Drugs Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Carbapenem Drugs Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Carbapenem Drugs Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Carbapenem Drugs Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Carbapenem Drugs Production Market Share (2021-2026)
Table 37. China Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Carbapenem Drugs Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Carbapenem Drugs Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Carbapenem Drugs Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Carbapenem Drugs Production Market Share (2021-2026)
Table 42. Rest of World Based Carbapenem Drugs Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Carbapenem Drugs Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Carbapenem Drugs Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Carbapenem Drugs Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Carbapenem Drugs Production Market Share (2021-2026)
Table 47. World Carbapenem Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Carbapenem Drugs Production by Type (2021-2026) & (K Units)
Table 49. World Carbapenem Drugs Production by Type (2027-2032) & (K Units)
Table 50. World Carbapenem Drugs Production Value by Type (2021-2026) & (USD Million)
Table 51. World Carbapenem Drugs Production Value by Type (2027-2032) & (USD Million)
Table 52. World Carbapenem Drugs Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Carbapenem Drugs Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Carbapenem Drugs Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 55. World Carbapenem Drugs Production by Dosage Form (2021-2026) & (K Units)
Table 56. World Carbapenem Drugs Production by Dosage Form (2027-2032) & (K Units)
Table 57. World Carbapenem Drugs Production Value by Dosage Form (2021-2026) & (USD Million)
Table 58. World Carbapenem Drugs Production Value by Dosage Form (2027-2032) & (USD Million)
Table 59. World Carbapenem Drugs Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 60. World Carbapenem Drugs Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 61. World Carbapenem Drugs Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Table 62. World Carbapenem Drugs Production by Clinical Indication (2021-2026) & (K Units)
Table 63. World Carbapenem Drugs Production by Clinical Indication (2027-2032) & (K Units)
Table 64. World Carbapenem Drugs Production Value by Clinical Indication (2021-2026) & (USD Million)
Table 65. World Carbapenem Drugs Production Value by Clinical Indication (2027-2032) & (USD Million)
Table 66. World Carbapenem Drugs Average Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 67. World Carbapenem Drugs Average Price by Clinical Indication (2027-2032) & (US$/Unit)
Table 68. World Carbapenem Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Carbapenem Drugs Production by Application (2021-2026) & (K Units)
Table 70. World Carbapenem Drugs Production by Application (2027-2032) & (K Units)
Table 71. World Carbapenem Drugs Production Value by Application (2021-2026) & (USD Million)
Table 72. World Carbapenem Drugs Production Value by Application (2027-2032) & (USD Million)
Table 73. World Carbapenem Drugs Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Carbapenem Drugs Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Gland Pharma Basic Information, Manufacturing Base and Competitors
Table 76. Gland Pharma Major Business
Table 77. Gland Pharma Carbapenem Drugs Product and Services
Table 78. Gland Pharma Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Gland Pharma Recent Developments/Updates
Table 80. Gland Pharma Competitive Strengths & Weaknesses
Table 81. Merck Basic Information, Manufacturing Base and Competitors
Table 82. Merck Major Business
Table 83. Merck Carbapenem Drugs Product and Services
Table 84. Merck Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Merck Recent Developments/Updates
Table 86. Merck Competitive Strengths & Weaknesses
Table 87. Savior Lifetec Basic Information, Manufacturing Base and Competitors
Table 88. Savior Lifetec Major Business
Table 89. Savior Lifetec Carbapenem Drugs Product and Services
Table 90. Savior Lifetec Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Savior Lifetec Recent Developments/Updates
Table 92. Savior Lifetec Competitive Strengths & Weaknesses
Table 93. Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 94. Sumitomo Pharma Major Business
Table 95. Sumitomo Pharma Carbapenem Drugs Product and Services
Table 96. Sumitomo Pharma Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Sumitomo Pharma Recent Developments/Updates
Table 98. Sumitomo Pharma Competitive Strengths & Weaknesses
Table 99. Pfizer Basic Information, Manufacturing Base and Competitors
Table 100. Pfizer Major Business
Table 101. Pfizer Carbapenem Drugs Product and Services
Table 102. Pfizer Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Pfizer Recent Developments/Updates
Table 104. Pfizer Competitive Strengths & Weaknesses
Table 105. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 106. Aurobindo Pharma Major Business
Table 107. Aurobindo Pharma Carbapenem Drugs Product and Services
Table 108. Aurobindo Pharma Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Aurobindo Pharma Recent Developments/Updates
Table 110. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 111. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 112. Daewoong Pharmaceutical Major Business
Table 113. Daewoong Pharmaceutical Carbapenem Drugs Product and Services
Table 114. Daewoong Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Daewoong Pharmaceutical Recent Developments/Updates
Table 116. Daewoong Pharmaceutical Competitive Strengths & Weaknesses
Table 117. ACS Dobfar Basic Information, Manufacturing Base and Competitors
Table 118. ACS Dobfar Major Business
Table 119. ACS Dobfar Carbapenem Drugs Product and Services
Table 120. ACS Dobfar Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. ACS Dobfar Recent Developments/Updates
Table 122. ACS Dobfar Competitive Strengths & Weaknesses
Table 123. Fresenius Basic Information, Manufacturing Base and Competitors
Table 124. Fresenius Major Business
Table 125. Fresenius Carbapenem Drugs Product and Services
Table 126. Fresenius Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Fresenius Recent Developments/Updates
Table 128. Fresenius Competitive Strengths & Weaknesses
Table 129. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 130. Sun Pharmaceutical Major Business
Table 131. Sun Pharmaceutical Carbapenem Drugs Product and Services
Table 132. Sun Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Sun Pharmaceutical Recent Developments/Updates
Table 134. Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 135. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 136. Hikma Pharmaceuticals Major Business
Table 137. Hikma Pharmaceuticals Carbapenem Drugs Product and Services
Table 138. Hikma Pharmaceuticals Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Hikma Pharmaceuticals Recent Developments/Updates
Table 140. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 141. CSPC Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 142. CSPC Pharmaceutical Group Major Business
Table 143. CSPC Pharmaceutical Group Carbapenem Drugs Product and Services
Table 144. CSPC Pharmaceutical Group Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. CSPC Pharmaceutical Group Recent Developments/Updates
Table 146. CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
Table 147. Shenzhen Haibin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 148. Shenzhen Haibin Pharmaceutical Major Business
Table 149. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Product and Services
Table 150. Shenzhen Haibin Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 152. Shenzhen Haibin Pharmaceutical Competitive Strengths & Weaknesses
Table 153. JW Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 154. JW Pharmaceutical Major Business
Table 155. JW Pharmaceutical Carbapenem Drugs Product and Services
Table 156. JW Pharmaceutical Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. JW Pharmaceutical Recent Developments/Updates
Table 158. JW Pharmaceutical Competitive Strengths & Weaknesses
Table 159. Taiwan Biotech Basic Information, Manufacturing Base and Competitors
Table 160. Taiwan Biotech Major Business
Table 161. Taiwan Biotech Carbapenem Drugs Product and Services
Table 162. Taiwan Biotech Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Taiwan Biotech Recent Developments/Updates
Table 164. Taiwan Biotech Competitive Strengths & Weaknesses
Table 165. Zhuhai United Laboratories Basic Information, Manufacturing Base and Competitors
Table 166. Zhuhai United Laboratories Major Business
Table 167. Zhuhai United Laboratories Carbapenem Drugs Product and Services
Table 168. Zhuhai United Laboratories Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Zhuhai United Laboratories Recent Developments/Updates
Table 170. Zhuhai United Laboratories Competitive Strengths & Weaknesses
Table 171. Endo International Basic Information, Manufacturing Base and Competitors
Table 172. Endo International Major Business
Table 173. Endo International Carbapenem Drugs Product and Services
Table 174. Endo International Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Endo International Recent Developments/Updates
Table 176. Endo International Competitive Strengths & Weaknesses
Table 177. Apotex Basic Information, Manufacturing Base and Competitors
Table 178. Apotex Major Business
Table 179. Apotex Carbapenem Drugs Product and Services
Table 180. Apotex Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Apotex Recent Developments/Updates
Table 182. Apotex Competitive Strengths & Weaknesses
Table 183. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 184. Dr Reddy's Laboratories Major Business
Table 185. Dr Reddy's Laboratories Carbapenem Drugs Product and Services
Table 186. Dr Reddy's Laboratories Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Dr Reddy's Laboratories Recent Developments/Updates
Table 188. Dr Reddy's Laboratories Competitive Strengths & Weaknesses
Table 189. Chongqing Shenghuaxi Pharm Basic Information, Manufacturing Base and Competitors
Table 190. Chongqing Shenghuaxi Pharm Major Business
Table 191. Chongqing Shenghuaxi Pharm Carbapenem Drugs Product and Services
Table 192. Chongqing Shenghuaxi Pharm Carbapenem Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Chongqing Shenghuaxi Pharm Recent Developments/Updates
Table 194. Chongqing Shenghuaxi Pharm Competitive Strengths & Weaknesses
Table 195. Global Key Players of Carbapenem Drugs Upstream (Raw Materials)
Table 196. Global Carbapenem Drugs Typical Customers
Table 197. Carbapenem Drugs Typical Distributors
LIST OF FIGURES
Figure 1. Carbapenem Drugs Picture
Figure 2. World Carbapenem Drugs Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Carbapenem Drugs Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Carbapenem Drugs Production (2021-2032) & (K Units)
Figure 5. World Carbapenem Drugs Average Price (2021-2032) & (US$/Unit)
Figure 6. World Carbapenem Drugs Production Value Market Share by Region (2021-2032)
Figure 7. World Carbapenem Drugs Production Market Share by Region (2021-2032)
Figure 8. North America Carbapenem Drugs Production (2021-2032) & (K Units)
Figure 9. Europe Carbapenem Drugs Production (2021-2032) & (K Units)
Figure 10. China Carbapenem Drugs Production (2021-2032) & (K Units)
Figure 11. Japan Carbapenem Drugs Production (2021-2032) & (K Units)
Figure 12. Carbapenem Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Carbapenem Drugs Consumption (2021-2032) & (K Units)
Figure 15. World Carbapenem Drugs Consumption Market Share by Region (2021-2032)
Figure 16. United States Carbapenem Drugs Consumption (2021-2032) & (K Units)
Figure 17. China Carbapenem Drugs Consumption (2021-2032) & (K Units)
Figure 18. Europe Carbapenem Drugs Consumption (2021-2032) & (K Units)
Figure 19. Japan Carbapenem Drugs Consumption (2021-2032) & (K Units)
Figure 20. South Korea Carbapenem Drugs Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Carbapenem Drugs Consumption (2021-2032) & (K Units)
Figure 22. India Carbapenem Drugs Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Carbapenem Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Carbapenem Drugs Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Carbapenem Drugs Markets in 2025
Figure 26. United States VS China: Carbapenem Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Carbapenem Drugs Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Carbapenem Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Carbapenem Drugs Production Market Share 2025
Figure 30. China Based Manufacturers Carbapenem Drugs Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Carbapenem Drugs Production Market Share 2025
Figure 32. World Carbapenem Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Carbapenem Drugs Production Value Market Share by Type in 2025
Figure 34. Meropenem
Figure 35. Imipenem
Figure 36. Ertapenem
Figure 37. Doripenem
Figure 38. Others
Figure 39. World Carbapenem Drugs Production Market Share by Type (2021-2032)
Figure 40. World Carbapenem Drugs Production Value Market Share by Type (2021-2032)
Figure 41. World Carbapenem Drugs Average Price by Type (2021-2032) & (US$/Unit)
Figure 42. World Carbapenem Drugs Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 43. World Carbapenem Drugs Production Value Market Share by Dosage Form in 2025
Figure 44. Sterile Powder for Injection
Figure 45. Ready-to-use or Premixed Injection
Figure 46. Others
Figure 47. World Carbapenem Drugs Production Market Share by Dosage Form (2021-2032)
Figure 48. World Carbapenem Drugs Production Value Market Share by Dosage Form (2021-2032)
Figure 49. World Carbapenem Drugs Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 50. World Carbapenem Drugs Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Figure 51. World Carbapenem Drugs Production Value Market Share by Clinical Indication in 2025
Figure 52. Severe Hospital-acquired Infections
Figure 53. Drug-resistant Bacterial Infections
Figure 54. Others
Figure 55. World Carbapenem Drugs Production Market Share by Clinical Indication (2021-2032)
Figure 56. World Carbapenem Drugs Production Value Market Share by Clinical Indication (2021-2032)
Figure 57. World Carbapenem Drugs Average Price by Clinical Indication (2021-2032) & (US$/Unit)
Figure 58. World Carbapenem Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Carbapenem Drugs Production Value Market Share by Application in 2025
Figure 60. Hospital
Figure 61. Clinic
Figure 62. Others
Figure 63. World Carbapenem Drugs Production Market Share by Application (2021-2032)
Figure 64. World Carbapenem Drugs Production Value Market Share by Application (2021-2032)
Figure 65. World Carbapenem Drugs Average Price by Application (2021-2032) & (US$/Unit)
Figure 66. Carbapenem Drugs Industry Chain
Figure 67. Carbapenem Drugs Procurement Model
Figure 68. Carbapenem Drugs Sales Model
Figure 69. Carbapenem Drugs Sales Channels, Direct Sales, and Distribution
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Carbapenem Drugs Picture
Figure 2. World Carbapenem Drugs Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Carbapenem Drugs Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Carbapenem Drugs Production (2021-2032) & (K Units)
Figure 5. World Carbapenem Drugs Average Price (2021-2032) & (US$/Unit)
Figure 6. World Carbapenem Drugs Production Value Market Share by Region (2021-2032)
Figure 7. World Carbapenem Drugs Production Market Share by Region (2021-2032)
Figure 8. North America Carbapenem Drugs Production (2021-2032) & (K Units)
Figure 9. Europe Carbapenem Drugs Production (2021-2032) & (K Units)
Figure 10. China Carbapenem Drugs Production (2021-2032) & (K Units)
Figure 11. Japan Carbapenem Drugs Production (2021-2032) & (K Units)
Figure 12. Carbapenem Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Carbapenem Drugs Consumption (2021-2032) & (K Units)
Figure 15. World Carbapenem Drugs Consumption Market Share by Region (2021-2032)
Figure 16. United States Carbapenem Drugs Consumption (2021-2032) & (K Units)
Figure 17. China Carbapenem Drugs Consumption (2021-2032) & (K Units)
Figure 18. Europe Carbapenem Drugs Consumption (2021-2032) & (K Units)
Figure 19. Japan Carbapenem Drugs Consumption (2021-2032) & (K Units)
Figure 20. South Korea Carbapenem Drugs Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Carbapenem Drugs Consumption (2021-2032) & (K Units)
Figure 22. India Carbapenem Drugs Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Carbapenem Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Carbapenem Drugs Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Carbapenem Drugs Markets in 2025
Figure 26. United States VS China: Carbapenem Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Carbapenem Drugs Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Carbapenem Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Carbapenem Drugs Production Market Share 2025
Figure 30. China Based Manufacturers Carbapenem Drugs Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Carbapenem Drugs Production Market Share 2025
Figure 32. World Carbapenem Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Carbapenem Drugs Production Value Market Share by Type in 2025
Figure 34. Meropenem
Figure 35. Imipenem
Figure 36. Ertapenem
Figure 37. Doripenem
Figure 38. Others
Figure 39. World Carbapenem Drugs Production Market Share by Type (2021-2032)
Figure 40. World Carbapenem Drugs Production Value Market Share by Type (2021-2032)
Figure 41. World Carbapenem Drugs Average Price by Type (2021-2032) & (US$/Unit)
Figure 42. World Carbapenem Drugs Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 43. World Carbapenem Drugs Production Value Market Share by Dosage Form in 2025
Figure 44. Sterile Powder for Injection
Figure 45. Ready-to-use or Premixed Injection
Figure 46. Others
Figure 47. World Carbapenem Drugs Production Market Share by Dosage Form (2021-2032)
Figure 48. World Carbapenem Drugs Production Value Market Share by Dosage Form (2021-2032)
Figure 49. World Carbapenem Drugs Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 50. World Carbapenem Drugs Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Figure 51. World Carbapenem Drugs Production Value Market Share by Clinical Indication in 2025
Figure 52. Severe Hospital-acquired Infections
Figure 53. Drug-resistant Bacterial Infections
Figure 54. Others
Figure 55. World Carbapenem Drugs Production Market Share by Clinical Indication (2021-2032)
Figure 56. World Carbapenem Drugs Production Value Market Share by Clinical Indication (2021-2032)
Figure 57. World Carbapenem Drugs Average Price by Clinical Indication (2021-2032) & (US$/Unit)
Figure 58. World Carbapenem Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Carbapenem Drugs Production Value Market Share by Application in 2025
Figure 60. Hospital
Figure 61. Clinic
Figure 62. Others
Figure 63. World Carbapenem Drugs Production Market Share by Application (2021-2032)
Figure 64. World Carbapenem Drugs Production Value Market Share by Application (2021-2032)
Figure 65. World Carbapenem Drugs Average Price by Application (2021-2032) & (US$/Unit)
Figure 66. Carbapenem Drugs Industry Chain
Figure 67. Carbapenem Drugs Procurement Model
Figure 68. Carbapenem Drugs Sales Model
Figure 69. Carbapenem Drugs Sales Channels, Direct Sales, and Distribution
Figure 70. Methodology
Figure 71. Research Process and Data Source
